---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-117228"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:15:42.913615+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eyenovia Q3 net loss $7.3M; acquired US rights to APP13007; appointed new director

## Summary
- Net loss of ~$7.3M ($0.18 EPS) in Q3 2023, vs ~$7.3M loss ($0.21 EPS) in Q3 2022.
- Cash & equivalents $20.7M at Sept 30, 2023, down from $22.9M at Dec 31, 2022.
- Acquired US commercial rights to APP13007 (post-surgical ocular pain/inflammation); PDUFA date March 4, 2024.
- FDA approved Coastline International as Mydcombi contract manufacturer; national launch planned early 2024.
- Michael Geltzeiler appointed as independent director and Audit Committee chair, effective Nov 14, 2023.

## SEC filing metadata
- accession: 0001104659-23-117228
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465923117228/0001104659-23-117228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465923117228/tm2330550d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-117228
- JSON: https://secwatch.observer/filing/0001104659-23-117228.json
- Plain text: https://secwatch.observer/filing/0001104659-23-117228.txt

## Key facts
- Earnings Releases
  HYPERION DEFI, INC. reported the third quarter ended September 30, 2023 results: net income approximately $(7.3) million, EPS $(0.18) per share.
  - Period: the third quarter ended September 30, 2023
  - Net income: approximately $(7.3) million
  - EPS: $(0.18) per share
  - Result: reported results
  source text: For the third quarter of 2023, net loss was approximately $(7.3) million, or $(0.18) per share compared to a net loss of approximately $(7.3) million, or $(0.21) per share, for the third quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465923117228/0001104659-23-117228-index.htm
- Executive change
  Michael Geltzeiler was appointed as Director and Chair of Audit Committee at HYPERION DEFI, INC..
  - Action: appointed
  - Role: Director and Chair of Audit Committee
  source text: On November 10, 2023, the Board of Directors (the “Board”) of the Company appointed Michael Geltzeiler to serve on the Board and as the Chair of the Audit Committee of the Board (the “Audit Committee”), in each case, effective November 14, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465923117228/0001104659-23-117228-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.